TipRanks
TipRanksTop Financial ExpertsInsidersCarlyle Group L.P.

Carlyle Group L.P. Insider Profile

11 Followers
Carlyle Group L.P., Ten Percent Owner at Medline, holds 125.45M shares in Medline (Ticker: MDLN), holds 84.59M shares in StandardAero, Inc. (Ticker: SARO), holds 1.99M shares in SunPower Inc (Ticker: SPWR).
See the Hottest Stocks Based on Insider Trading >
tipranks
Carlyle Group L.P.

Carlyle Group L.P.
Medline (MDLN)
Ten Percent Owner

Ranked #20,194 out of 109,106 Corporate Insiders

Profitable Transactions

64%
16 out of 25 Profitable Transactions

Average Return

+4.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$9B
50.23%
22.29%
19.88%
4.61%
2.99% Others
A breakdown of Carlyle Group L.P.'s holdings
See the Top Stocks by Insiders

Insider Roles

Medline
(MDLN)
Ten Percent Owner
StandardAero, Inc.
(SARO)
Ten Percent Owner
MKS
(MKSI)
Ten Percent Owner
Vistance Networks
(VISN)
Ten Percent Owner
+5 other positions
Roles that Carlyle Group L.P. holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Soleno Therapeutics
(SLNO)
Rating:Informative Buy
Date:Oct 02, 2023 - Oct 02, 2024
Return:+87.60%
The most profitable trade made by Carlyle Group L.P.
See the Latest Stocks Traded by Insiders

Carlyle Group L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MDLN
Medline
Mar 12, 2026
Ten Percent Owner
Uninformative Sell
―
$4.30B
VISN
Vistance Networks
Nov 18, 2016
Ten Percent Owner
Informative Sell
654.80M
$394.85M
GTM
ZoomInfo Technologies
Aug 17, 2022
Former 10% owner
Uninformative Sell
8.53M
$157.20M
OCDX
Ortho Clinical Diagnostics Holdings
Sep 16, 2021
―
Informative Sell
425.04M
$2.08B
VERA
Vera Therapeutics
Aug 19, 2022
Ten Percent Owner
Uninformative Buy
109.17K
$97.84M
JSPR
Jasper Therapeutics
Feb 12, 2024
Former 10% Owner
Informative Buy
2.46M
$603.46K
MKSI
MKS
May 10, 2023
Ten Percent Owner
Informative Sell
172.24M
$1.70B
SLNO
Soleno Therapeutics
Oct 02, 2023
―
Informative Buy
1.91M
$81.18M
QDEL
QuidelOrtho
Nov 21, 2024
Ten Percent Owner
Informative Sell
291.67M
$0.00
SPWR
SunPower Inc
Dec 04, 2024
Ten Percent Owner
Uninformative Sell
56.88K
$597.73K
SARO
StandardAero, Inc.
Mar 02, 2026
Ten Percent Owner
Informative Sell
624.17M
$1.91B
List of latest transactions for each holding click on a transaction to see Carlyle Group L.P.'s performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Carlyle Group L.P. insider profile FAQ

What is the percentage of profitable transactions made by Carlyle Group L.P.?
The percentage of profitable transactions made by Carlyle Group L.P. is 64%.
    What is the average return per transaction made by Carlyle Group L.P.?
    The average return per transaction made by Carlyle Group L.P. is 4.20%.
      What stocks does Carlyle Group L.P. hold?
      Carlyle Group L.P. holds: MDLN, VISN, GTM, OCDX, VERA, JSPR, MKSI, SLNO, QDEL, SPWR, SARO stocks.
        What was Carlyle Group L.P.’s latest transaction?
        Carlyle Group L.P. latest transaction was an Uninformative Sell of ―.
          What was Carlyle Group L.P.'s most profitable transaction?
          Carlyle Group L.P.’s most profitable transaction was an Informative Buy of SLNO stock on October 2, 2023. The return on the trade was 87.60%.
            What is Carlyle Group L.P.'s role in Medline?
            Carlyle Group L.P.'s role in Medline is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.